Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jan;32(1):42-53.
doi: 10.1016/j.semradonc.2021.09.001.

Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology

Jessica A Scarborough  1 , Jacob G Scott  2
Affiliations
Review

Translation of Precision Medicine Research Into Biomarker-Informed Care in Radiation Oncology

Jessica A Scarborough et al. Semin Radiat Oncol. 2022 Jan.

Abstract

The reach of personalized medicine in radiation oncology has expanded greatly over the past few decades as technical precision has improved the delivery of radiation to each patient's unique anatomy. Yet, the consideration of biological heterogeneity between patients has largely not been translated to clinical care. There are innumerable promising advancements in the discovery and validation of biomarkers, which could be used to alter radiation therapy directly or indirectly. Directly, biomarker-informed care may alter treatment dose or identify patients who would benefit most from radiation therapy and who could safely avoid more aggressive care. Indirectly, a variety of biomarkers could assist with choosing the best radiosensitizing chemotherapies. The translation of these advancements into clinical practice will bring radiation oncology even further into the era of precision medicine, treating patients according to their unique anatomical and biological differences.

Keywords: Biomarkers; Genomics; Precision medicine; Radiotherapy response prediction; Transcriptomics.

PubMed Disclaimer

References

    1. Oldenhuis CNAM, Oosting SF, Gietema JA, and De Vries EGE. Prognostic versus predictive value of biomarkers in oncology. European journal of cancer, 44(7):946–953, 2008. - PubMed
    1. Ballman Karla V. Biomarker: predictive or prognostic? Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 33(33):3968–3971, 2015. - PubMed
    1. Huang Rui-Xue and Zhou Ping-Kun. Dna damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal transduction and targeted therapy, 5(1):1–27, 2020. - PMC - PubMed
    1. Maria Weber Anika and Joseph Ryan Anderson. Atm and atr as therapeutic targets in cancer. Pharmacology & therapeutics, 149:124–138, 2015. - PubMed
    1. Pitter Kenneth L, Casey Dana L, Lu Yue C, Hannum Margaret, Zhang Zhigang, Song Xinmao, Pecorari Isabella, McMillan Biko, Ma Jennifer, Samstein Robert M, et al. Pathogenic atm mutations in cancer and a genetic basis for radiotherapeutic efficacy. JNCI: Journal of the National Cancer Institute, 113(3):266–273, 2021. - PMC - PubMed

Publication types